[HTML][HTML] Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - ncbi.nlm.nih.gov
Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …
and after various anticancer treatments which can continue for many years after treatment …
Prevalence of Fatigue Among Cancer Patients Receiving Various Anticancer Therapies and its Impact on Quality of Life: A Cross-Sectional Study.
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - search.ebscohost.com
Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …
and after various anticancer treatments which can continue for many years after treatment …
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study
G Karthikeyan, D Jumnani, R Prabhu… - Indian journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Fatigue is disabling and continuous phenomenon in cancer patients during and
after various anticancer treatments which can continue for many years after treatment and …
after various anticancer treatments which can continue for many years after treatment and …
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study.
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - europepmc.org
Background Fatigue is disabling and continuous phenomenon in cancer patients during and
after various anticancer treatments which can continue for many years after treatment and …
after various anticancer treatments which can continue for many years after treatment and …
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on Quality of Life: A cross-sectional study
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - search.proquest.com
Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …
and after various anticancer treatments which can continue for many years after treatment …
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on Quality of Life: A cross-sectional study
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - go.gale.com
Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …
and after various anticancer treatments which can continue for many years after treatment …
[PDF][PDF] Prevalence of Fatigue Among Cancer Patients Receiving Various Anticancer Therapies and its Impact on Quality of Life: A Cross-Sectional Study
G Karthikeyan, D Jumnani, R Prabhu, UK Manoor… - academia.edu
Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …
and after various anticancer treatments which can continue for many years after treatment …
Prevalence of Fatigue Among Cancer Patients Receiving Various Anticancer Therapies and its Impact on Quality of Life: A Cross-Sectional Study.
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - search.ebscohost.com
Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …
and after various anticancer treatments which can continue for many years after treatment …
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study.
G Karthikeyan, D Jumnani, R Prabhu… - Indian Journal of …, 2012 - europepmc.org
Background Fatigue is disabling and continuous phenomenon in cancer patients during and
after various anticancer treatments which can continue for many years after treatment and …
after various anticancer treatments which can continue for many years after treatment and …